Tactile Systems Technology, Inc. (TCMD) Stock Price

TCMDStock

$22.52+53.30%52W

Market Cap$510.13M

P/E26.73x

PEG Ratio17.79

Div yield—

Beta0.89

TCMD Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-20.04%

Price vs S&P 500 (4W)-0.12%

PEG Ratio17.79

VGM Score70.56

P/E Ratio (Annual)26.73x

P/CF (Annual)11.92x

Book Value / Share (Quarterly)$9.86

P/TBV (Annual)3.60x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)10.11%

Cash Flow / Share (Quarterly)$1.17

Price vs S&P 500 (YTD)-34.27%

Gross Margin (TTM)51.94%

Net Profit Margin (TTM)7.10%

EPS (TTM)$1.08

10-Day Avg Trading Volume0.21M

EPS Excl Extra (TTM)$1.08

Revenue Growth (5Y)11.99%

EPS (Annual)$0.82

ROI (Annual)8.72%

Gross Margin (Annual)50.79%

Net Profit Margin (5Y Avg)1.81%

Cash / Share (Quarterly)$3.73

P/E Basic Excl Extra (TTM)20.52x

Revenue Growth QoQ (YoY)8.61%

P/E Normalized (Annual)26.73x

ROA (Last FY)6.97%

Revenue Growth TTM (YoY)17.22%

EBITD / Share (TTM)$1.64

ROE (5Y Avg)1.47%

Operating Margin (TTM)10.00%

Cash Flow / Share (Annual)$1.79

P/B Ratio2.28x

P/B Ratio (Quarterly)3.00x

Net Income / Employee (Annual)$17,600

EV / Revenue (TTM)1.26x

ROA (TTM)9.17%

EPS Growth QoQ (YoY)143.93%

EV / EBITDA (TTM)11.75x

EPS Incl Extra (Annual)$0.82

Current Ratio (Annual)4.03x

Quick Ratio (Quarterly)3.37x

3-Month Avg Trading Volume0.28M

52-Week Price Return53.30%

EV / Free Cash Flow (Annual)10.93x

P/E Incl Extra (TTM)20.52x

Revenue / Employee (TTM)$322,600

Tangible BV / Share (Quarterly)$7.89

P/S Ratio (Annual)1.55x

Asset Turnover (Annual)1.20x

52-Week High$37.77

Operating Margin (5Y Avg)3.40%

EPS Excl Extra (Annual)$0.82

CapEx CAGR (5Y)2.05%

Tangible BV CAGR (5Y)7.86%

26-Week Price Return-10.14%

Quick Ratio (Annual)3.49x

13-Week Price Return-21.64%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)4.12x

Enterprise Value$440.28M

Revenue / Share Growth (5Y)7.85%

Asset Turnover (TTM)1.29x

Book Value / Share Growth (5Y)8.80%

Revenue / Employee (Annual)$303,400

Inventory Turnover (Annual)9.92x

Pretax Margin (Annual)9.51%

Cash / Share (Annual)$4.42

3-Month Return Std Dev44.29%

Gross Margin (5Y Avg)49.45%

Net Income / Employee (TTM)$22,900

EBITDA CAGR (5Y)141.02%

EBITDA Interim CAGR (5Y)67.92%

ROE (Last FY)8.72%

EPS Basic Excl Extra (Annual)$0.82

P/FCF (TTM)18.32x

Receivables Turnover (TTM)9.19x

EV / Free Cash Flow (TTM)16.51x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$1.08

Receivables Turnover (Annual)7.42x

ROI (TTM)11.49%

P/S Ratio (TTM)1.46x

Pretax Margin (5Y Avg)3.18%

Revenue / Share (Annual)$14.15

Tangible BV / Share (Annual)$8.01

Forward P/E16.42x

Free OCF CAGR (5Y)140.56%

Price vs S&P 500 (52W)37.77%

P/E Ratio (TTM)20.52x

EPS Growth TTM (YoY)73.09%

Year-to-Date Return-22.34%

5-Day Price Return-0.44%

EPS Normalized (Annual)$0.82

ROA (5Y Avg)2.19%

Net Profit Margin (Annual)5.79%

Month-to-Date Return1.03%

Cash Flow / Share (TTM)$1.42

EBITD / Share (Annual)$1.36

Operating Margin (Annual)8.89%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)16.70x

ROI (5Y Avg)2.31%

P/E Excl Extra (TTM)20.52x

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$1.08

P/TBV (Quarterly)3.75x

P/B Ratio (Annual)2.96x

Inventory Turnover (TTM)9.92x

Pretax Margin (TTM)10.66%

Book Value / Share (Annual)$9.76

Price vs S&P 500 (13W)-24.33%

Beta0.89x

P/FCF (Annual)12.67x

Revenue / Share (TTM)$15.19

ROE (TTM)11.49%

52-Week Low$14.44

vGradeB

gGradeB

mGradeB

vgmGradeB

TCMD Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 10, 2026	$0.17	$0.36	+111.76%(+$0.19)
Q1 2026	May 4, 2026	-$0.04	$0.00	+106.86%(+$0.04)
Q4 2025	Feb 17, 2026	$0.45	$0.46	+3.37%(+$0.02)
Q3 2025	Nov 3, 2025	$0.20	$0.36	+75.61%(+$0.16)
Q2 2025	Aug 4, 2025	$0.14	$0.14	-3.45%(-$0.01)

TCMD Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.27

4.30

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24
RCELAvita Medical, Inc. Common Stock	D	C	A	5.3x	19.6%	82.1%	-46.6%	$13.04

About Tactile Systems Technology, Inc.

Tactile Systems Technology develops home-based medical devices for chronic disease management. The company's proprietary platforms include FlexiTouch for lymphedema treatment and AcuTouch for chronic venous insufficiency, along with additional solutions for chronic swelling. These wearable and home-based therapies enable patients to manage their conditions outside clinical settings.

TCMD Next Earnings Report

Report dateNov 2, 2026

QuarterQ3 2026

Report timeAMC

EPS estimate$0.34

Revenue estimate$91.99M

Also reporting on Nov 2, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

TCMD Insider Transactions

SellAug 10, 2026
DODD SHERI LOUISE
Chief Executive Officer
Shares: 10,978Value: $323,243

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for August 2026

Companies in Related Industries

MLABMesa Laboratories IncIndustrial Instruments
CTKBCytek Biosciences, Inc. Common StockLab Analytical Instruments
AVRAnteris Technologies Global Corp. Common StockOrthopedic & Prosthetic Devices
PACBPacific Biosciences of California, Inc.Lab Analytical Instruments
MASS908 Devices Inc. Common StockLab Analytical Instruments
SENSSenseonics Holdings, Inc. Common StockIndustrial Instruments
FOSLFossil Group, Inc.Watches & Clocks
PREPrenetics Global Limited Class A Ordinary ShareLab Analytical Instruments

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.3

Strong Buy

Consensus rating

52-Week Range

Low$14.44

High$37.77